Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biodesix Inc
(NQ:
BDSX
)
1.960
+0.110 (+5.95%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biodesix Inc
< Previous
1
2
3
4
5
6
7
Next >
Biodesix Announces Third Quarter 2023 Results and Highlights
November 07, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023
October 24, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting
October 03, 2023
From
Biodesix, Inc.
Via
Business Wire
Recap: Biodesix Q1 Earnings
May 11, 2023
Via
Benzinga
Biodesix Earnings Perspective: Return On Capital Employed
March 09, 2023
Via
Benzinga
Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer
September 07, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in Two Upcoming Investor Conferences in September
September 05, 2023
From
Biodesix, Inc.
Via
Business Wire
Kingstone Companies And 3 Other Stocks Under $2 Insiders Are Buying
August 24, 2023
The Dow Jones closed higher by over 180 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer
August 22, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Second Quarter 2023 Results and Highlights
August 07, 2023
From
Biodesix, Inc.
Via
Business Wire
Top 5 Health Care Stocks That May Crash In Q3
August 07, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference
August 01, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023
July 24, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
July 12, 2023
From
Biodesix, Inc.
Via
Business Wire
Why Shares of CareDx Are Jumping Friday
July 07, 2023
The company's diagnostic tests may obtain better coverage from the Centers for Medicare & Medicaid Services.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 06, 2023
Via
Benzinga
Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT® Test by the Center for Medicare and Medicaid Services
July 06, 2023
From
Biodesix, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
July 06, 2023
It's time to start the day off right with a breakdown of the biggest pre-market stock movers traders need to watch on Thursday!
Via
InvestorPlace
Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier
June 27, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Three Abstracts to Be Presented at ASCO 2023 Annual Meeting
June 01, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in William Blair’s 43rd Annual Growth Stock Conference
May 31, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Four Presentations of Health Economic Data Highlighting Cost Saving Potential of Nodify Lung® Testing
May 25, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix, Inc. Chief Financial Officer Robin Harper Cowie Appointed to Colorado BioScience Association's Board of Directors
May 24, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to Be Presented at ATS 2023 International Conference
May 18, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces First Quarter 2023 Results and Highlights
May 11, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023
April 27, 2023
From
Biodesix, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 15, 2023
Via
Benzinga
Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights
March 06, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate at Cowen’s 43rd Annual Healthcare Conference
February 28, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
February 21, 2023
From
Biodesix, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.